Autori: Salmin F*

Filtra

Data

Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.

Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module

Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study

Long-term natural history in type II and III spinal muscular atrophy: a 4-year international study on the Hammersmith Functional Motor Scale Expanded

Assessing Prevalence and Characteristics of Oro-bulbar Involvement in Children and Adults with SMA Type 2 and 3 Using a Multimodal Approach

Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen

Nusinersen in pediatric and adult patients with type III spinal muscular atrophy

Type I SMA “new natural history”: long-term data in nusinersen-treated patients

Torna in alto